EPIPAGE 2 is a population-based prospective study in France scheduled to follow children up to the age of 12 years. Participants include all infants live-born or stillborn and all terminations of pregnancy between 22 and 31 completed weeks of gestation in all the maternity units in 25 French regions (21 of the 22 metropolitan regions and 4 overseas regions) during the inclusion period in 2011. In addition, a sample of moderate preterm births (i.e., births and late terminations at 32 to 34 weeks) was included in the same regions. Assessments included an interview with parents, a self-administered parental questionnaire, clinical examination by a paediatrician, and an evaluation by a psychologist, performed in 110 centres specifically opened for the study.
Study design
Cohort - birth
Number of participants at first data collection
7,804 (participants)
Age at first data collection
Birth (participants)
Participant year of birth
2011 (participants)
Participant sex
All
Representative sample at baseline?
The preterm population in France.
Sample features
Country
Year of first data collection
2011
Primary Institutions
National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, INSERM)
Links
epipage2.inserm.fr/index.php/en/study
Profile paper DOI
Funders
French Institute for Public Health Research (Institut français de recherche en santé publique, IReSP)
French National Research Agency (ANR)
La Fondation PremUp
Ongoing?
Yes
Data types collected
Engagement
Keywords
Consortia and dataset groups